DrChrono white logo mobile menu icon

Meaningful Use Stage 3

Meaningful Use, Done Easy

Get Started Schedule Demo

Start Attesting and Qualifying for Government Incentives

DrChrono is certified as a Complete EHR by the ONC-ATCB. Use DrChrono in your practice to qualify for government incentives per the HITECH Act

What is MU 3?

Stage 3 aims to develop the changes required to make the Meaningful Use program more flexible and less burdensome for providers. Additionally, creating clarity in the process, and promoting interoperability between your EHR and better patient outcomes. MU Stage 3 brings an emphasis on measures that allow for the exchange of health information between patients and providers, to ensure that you provide the best patient care you can give.

DrChrono continuously works to keep informed of changes to the MU program to ensure that you are able to meet necessary requirements.

Mac monitor with DrChrono's Billing Summary
meaningful use icon

The DrChrono EHR is 2015 compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

DrChrono EHR 11.0 was Stage 3 certified by InfoGard on 12/27/2018. Our EHR Vendor Certification ID is 15.02.02.2897.A083.01.00.0.181227.

  • CMS2v6
  • CMS50v5
  • CMW68v6
  • CMS69v5
  • CMS90v6
  • CMS122v5
  • CMS123v5
  • CMS130v5
  • CMS131v5
  • CMS137v5
  • CMS138v5
  • CMS156v5
  • CMS165v5
  • CMS166v6
  • 170.315(a)(1): Computerized Provider Order Entry (CPOE) - Medications
  • 170.315(a)(2): CPOE - Laboratory
  • 170.315(a)(3): CPOE - Diagnostic Imaging
  • 170.315(a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE
  • 170.315(a)(5): Demographics
  • 170.315(a)(6): Problem List
  • 170.315(a)(7): Medication List
  • 170.315(a)(8): Medication Allergy List
  • 170.315(a)(9) - Clinical decision support (CDS)
  • 170.315(a)(10): Drug-Formulary and Preferred Drug List Checks
  • 170.315(a)(11): Smoking Status
  • 170.315(a)(12): Family Health History
  • 170.315(a)(13): Patient-Specific Education Resources
  • 170.315(a)(14): Implantable Device List
  • 170.315(b)(1) – Transition of care
  • 170.315(b)(2): Clinical Information Reconciliation and Incorporation
  • 170.315(b)(3): Electronic Prescribing
  • 170.315(b)(4) - Common Clinical Data Set summary record –create
  • 170.315(b)(5) - Common Clinical Data Set summary record –receive
  • 170.315(b)(6) - Data export
  • 170.315(c)(1) - Clinical quality measures –record and export
  • 170.315(c)(2) - Clinical quality measures –import and calculate
  • 170.315(c)(3) - Clinical quality measures —report
  • 170.315(d)(1): Authentication, Access Control, Authorization
  • 170.315(d)(2): Auditable Events and Tamper-Resistance
  • 170.315(d)(3): Audit Report(s)
  • 170.315(d)(4): Amendments
  • 170.315(d)(5): Automatic Access Time-out
  • 170.315(d)(6): Emergency Access
  • 170.315(d)(7): End-User Device Encryption
  • 170.315(d)(8): Integrity
  • 170.315(d)(9): Trusted Connection
  • 170.315(d)(11): Accounting of Disclosures
  • 170.315(e)(1) - View, download, and transmit to 3rd party
  • 170.315(e)(2): Secure Messaging
  • 170.315(e)(3): Patient Health Information Capture
  • 170.315(f)(2) - Transmission to public health agencies—syndromic surveillance
  • 170.315(g)(3): Safety-Enhanced Design
  • 170.315(g)(4): Quality Management System
  • 170.315(g)(5): Accessibility-Centered Design
  • 170.315(g)(6): Consolidated CDA Creation
  • 170.315(g)(7): Application Access - Patient Selection
  • 170.315(g)(8) - Application access – data category request
  • 170.315(g)(9) - Application access –all data request
  • 170.315(h)(1) - Direct Project

Leveraged Software & Content:

  1. Surescripts
  2. Updox
  3. Duo Mobile
  4. Inflection ID Proofing

Costs and Limitations

(A) Additional types of costs that a user may be required to pay to implement or use the Complete EHR or Health IT Module’s capabilities, either to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification.

(B) Limitations a user may encounter in the course of implementing and using the Complete EHR or Health IT Module’s capabilities, either to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification.

(C) In order to implement and use the software according to its certification, a Hippocrates plan or higher is necessary. Electronic Prescribing capabilities, Direct Messaging, and Lab Integrations have per provider costs, without associated limits on volume. For a full explanation of features and limitations click here.

170.315(b)(3): Electronic Prescribing

Types of Costs: Duo + Inflection & Surescripts

170.315(e)(2): Secure Messaging

Types of Costs: Updox Direct Messaging